Lista de obras - Val Lewington - Dominio Público Uruguay

123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel

artículo científico publicado en 2016

18F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer Patients

artículo científico publicado en 2017

18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)

artículo científico publicado en 2011

68Ga-DOTATATE PET in neuroectodermal tumours: first experience

scientific article published on 01 May 2007

89Sr therapy: strontium plasma clearance in disseminated prostatic carcinoma

artículo científico publicado en 1989

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases

artículo científico publicado en 2015

A practical guide to targeted therapy for bone pain palliation.

artículo científico publicado en 2002

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone ⬇️

artículo científico publicado el 1 de enero de 1991

A survey of the role of the UK physicist in nuclear medicine: a report of a joint working group of the British Institute of Radiology, British Nuclear Medicine Society, and the Institute of Physics and Engineering in Medicine

artículo científico publicado en 2003

Cancer therapy using bone-seeking isotopes.

artículo científico publicado en 1996

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

artículo científico publicado en 2010

Development of 131I-tositumomab.

artículo científico publicado en 2005

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide

scientific article published on 28 August 2009

Gastrinoma (duodenal and pancreatic).

artículo científico publicado en 2006

Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidine

artículo científico publicado en 1989

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

artículo científico publicado en 2005

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

artículo científico publicado en 2011

Guidelines for the management of thyroid cancer

article

Intra-arterial brachytherapy of hepatic malignancies: watch the flow

artículo científico publicado en 2010

Isotopic evaluation and therapy in patients with malignant endocrine disease.

artículo científico publicado en 2001

Measurements of the strontium plasma clearance rate in patients receiving 89Sr radionuclide therapy

artículo científico publicado en 1989

Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.

artículo científico publicado en 1988

Molecular radiotheragnostics in thyroid disease

artículo científico publicado en 2017

Nuclear medicine innovations help (drive) healthcare (benefits).

artículo científico publicado en 2015

Nuclear medicine training and practice in the UK.

artículo científico publicado en 2015

Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management

artículo científico publicado en 2017

Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?

artículo científico publicado el 1 de marzo de 1992

Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

artículo científico publicado en 2008

Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer

artículo científico publicado en 2017

Pulmonary embolism. Is the clinical history a useful adjunct to aid the interpretation of the equivocal lung scan?

scientific article published on 01 March 1996

Radionuclide therapy

artículo científico publicado en 1999

Radionuclide therapy practice and facilities in Europe. EANM Radionuclide Therapy Committee

artículo científico publicado en 1999

Re-assessing gallium-67 as a therapeutic radionuclide.

artículo científico publicado en 2016

Report of a European consensus workshop to develop recommendations for the optimal use of (90)Y-ibritumomab tiuxetan (Zevalin) in lymphoma.

artículo científico publicado en 2005

Role of SPECT/CT in differentiated thyroid cancer.

artículo científico publicado en 2012

Targeted radionuclide therapy for bone metastases.

artículo científico publicado en 1993

Targeted radionuclide therapy for neuroendocrine tumours: principles and application.

artículo científico publicado en 2009

The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer

artículo científico publicado en 2010

The qualified person in radiopharmacy

scientific article published on 01 March 2010

The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.

artículo científico publicado en 2008

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.

artículo científico publicado en 2017

Lista de obras de Val Lewington

123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel

18F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer Patients

18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)

68Ga-DOTATATE PET in neuroectodermal tumours: first experience

89Sr therapy: strontium plasma clearance in disseminated prostatic carcinoma

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases

A practical guide to targeted therapy for bone pain palliation.

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone ⬇️

A survey of the role of the UK physicist in nuclear medicine: a report of a joint working group of the British Institute of Radiology, British Nuclear Medicine Society, and the Institute of Physics and Engineering in Medicine

Cancer therapy using bone-seeking isotopes.

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

Development of 131I-tositumomab.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide

Gastrinoma (duodenal and pancreatic).

Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidine

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

Guidelines for the management of thyroid cancer

Intra-arterial brachytherapy of hepatic malignancies: watch the flow

Isotopic evaluation and therapy in patients with malignant endocrine disease.

Measurements of the strontium plasma clearance rate in patients receiving 89Sr radionuclide therapy

Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.

Molecular radiotheragnostics in thyroid disease

Nuclear medicine innovations help (drive) healthcare (benefits).

Nuclear medicine training and practice in the UK.

Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management

Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?

Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer

Pulmonary embolism. Is the clinical history a useful adjunct to aid the interpretation of the equivocal lung scan?

Radionuclide therapy

Radionuclide therapy practice and facilities in Europe. EANM Radionuclide Therapy Committee

Re-assessing gallium-67 as a therapeutic radionuclide.

Report of a European consensus workshop to develop recommendations for the optimal use of (90)Y-ibritumomab tiuxetan (Zevalin) in lymphoma.

Role of SPECT/CT in differentiated thyroid cancer.

Targeted radionuclide therapy for bone metastases.

Targeted radionuclide therapy for neuroendocrine tumours: principles and application.

The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer

The qualified person in radiopharmacy

The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.